Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Mrózek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431–448.

    Article  Google Scholar 

  2. Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55–59.

    CAS  PubMed  Google Scholar 

  3. Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14: 796–804.

    Article  CAS  Google Scholar 

  4. Döhner K, Tobis K, Ulrich R, Fröhling S, Benner A, Schlenk RF et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002; 20: 3254–3261.

    Article  Google Scholar 

  5. Whitman SP, Ruppert AS, Marcucci G, Mrózek K, Paschka P, Langer C et al. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B Study. Blood 2007; 109: 5164–5167.

    Article  CAS  Google Scholar 

  6. Schlenk RF, Döhner K, Kneba M, Götze K, Hartmann F, Del Valle F et al. Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. Haematologica 2009; 94: 54–60.

    Article  CAS  Google Scholar 

  7. Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 237–251.

    Article  CAS  Google Scholar 

  8. Schnittger S, Dicker F, Kern W, Wendland N, Sundermann J, Alpermann T et al. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Blood 2011; 117: 2348–2357.

    Article  CAS  Google Scholar 

  9. Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K et al. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood 2008; 112: 2013–2016.

    Article  CAS  Google Scholar 

  10. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

    Article  Google Scholar 

  11. Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605–1616.

    Article  CAS  Google Scholar 

  12. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009; 113: 3314–3322.

    Article  CAS  Google Scholar 

  13. García P, Frampton J . Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor. Dev Cell 2008; 14: 815–816.

    Article  Google Scholar 

  14. Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM . c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis. J Clin Invest 2010; 120: 593–606.

    Article  CAS  Google Scholar 

  15. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci USA 2005; 102: 8603–8608.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms Donna Bucci of the CALGB Leukemia Tissue Bank and the Ohio State University Comprehensive Cancer Center's Nucleic Acid and Microarray Shared Resources for their technical support. We thank participating institutions, medical professionals and AML patients for their valuable involvement with this study. This work was supported in part by the National Cancer Institute (Bethesda, MD, USA) Grants CA140158, CA101140, CA114725, CA31946, CA33601, CA16058, CA77658, CA089341 and CA129657, the Coleman Leukemia Research Foundation (to Dr Bloomfield) and the Deutsche Krebshilfe—Dr Mildred Scheel Cancer Foundation (to Dr Becker).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to M A Caligiuri or C D Bloomfield.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whitman, S., Caligiuri, M., Maharry, K. et al. The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia. Leukemia 26, 1713–1717 (2012). https://doi.org/10.1038/leu.2012.34

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.34

This article is cited by

Search

Quick links